International Stem Cell Balance Sheet Health
Financial Health criteria checks 3/6
International Stem Cell has a total shareholder equity of $36.0K and total debt of $3.5M, which brings its debt-to-equity ratio to 9694.4%. Its total assets and total liabilities are $5.4M and $5.3M respectively.
Key information
9,694.4%
Debt to equity ratio
US$3.49m
Debt
Interest coverage ratio | n/a |
Cash | US$1.39m |
Equity | US$36.00k |
Total liabilities | US$5.33m |
Total assets | US$5.37m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ISCO's short term assets ($3.6M) do not cover its short term liabilities ($5.0M).
Long Term Liabilities: ISCO's short term assets ($3.6M) exceed its long term liabilities ($367.0K).
Debt to Equity History and Analysis
Debt Level: ISCO's net debt to equity ratio (5844.4%) is considered high.
Reducing Debt: ISCO's debt to equity ratio has increased from 31.4% to 9694.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable ISCO has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: ISCO is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 45% per year.